CONNECT WITH US
Funding Tracker

Funding Tracker

Preventive health startup Cent raises $15 million to advance early disease detection and health monitoring

Indian Startup News – Funding logo

Published on

Add as a preferred source on Google
Preventive health startup Cent raises $15 million to advance early disease detection and health monitoring

Cent, a preventive health intelligence startup, has raised $15 million in a Series A funding round led by Blume Ventures and existing investor South Park Commons.

The round, which includes equity and debt, also saw participation from individual investors such as Arun Sarin, former CEO of Vodafone; Srinivas Narayanan, former CTO (B2B) of OpenAI; Sharath Narayana, Krishna Sridhar and Aprameya Radhakrishna.

Founded in 2025 by Shashank ND, founder of Practo and OneFlow Holdings; Anshul Khandelwal, former CMO of Ola Electric; and Arpit Garg, former product head at Lenskart, Cent focuses on the early detection and monitoring of diseases, including cardiovascular conditions, cancer and metabolic disorders.

The startup is developing a preventive healthcare platform that integrates specialised hardware, AI-based radiology and diagnostics, and bioinformatics.

According to the company, the platform is designed to help identify potential health risks before symptoms appear and monitor patients' health over time.

It plans to use the funding to support research and development, further develop its technology platform, and expand its AI, engineering and clinical teams.

"India's healthcare system is still built to treat illness, not to find it early. We believe the next shift is preventive care that is precise and accessible at scale. Our first 10,000 scans have shown us how much that shift is needed. This investment lets us go deeper into AI, medical imaging and clinical research, and build preventive health infrastructure in India that can serve the world," said Anshul Khandelwal.

"When we were introduced to Shashank and the team that came together to build Cent, we saw an obsessive ambition to solve for accurate diagnosis and protocols for cancers amongst other indications.


Source link
Related Topics:Funding Tracker

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.